Clinical trial data presented at SMSNA
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Futura Medical plc (AIM: FUM), the consumer healthcare company behind Eroxon®, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, announces that three abstracts on MED3000 are being presented at the Sexual Medicine Society of North America (SMSNA) at their annual conference in Scottsdale, Arizona on 17th to 20th October. The SMSNA promotes, encourages, and supports the highest standards of practice, research, education, and ethics in the study of human sexual function and dysfunction.
The abstracts detail the results of clinical trials, showing the positive impact of MED3000 on Erectile Dysfunction (ED) but also self-esteem and relationships in men with ED and sexual encounter profiles for men and their partners.
The importance of the presentation of these abstracts is to educate and improve awareness amongst key opinion leaders and other healthcare practitioners about the benefits of MED3000 (now available through the USA under the brand name Eroxon®) as a clinical proven treatment for ED.
Details of the of the abstracts, methods and results can be found at: https://www.smsna.org/annual2024/program
| Abstract 1 | Topical Administration of MED3000 Gel Significantly Improves Self-esteem and Relationships in Men with Erectile Dysfunction: Results from Two Clinical Trials |
| Abstract 2 | Topical Administration of MED3000 Gel Significantly Improves Erectile Function in Men with Mild, Moderate, or Severe Erectile Dysfunction: Results from Two Multicenter Clinical Trials |
| Abstract 3 | Topical Administration of MED3000 Gel Significantly Improves All Aspects of the Sexual Encounter Profile for Both Men and Their Partners |
The abstracts are presented to the audience and then all abstracts presented at the meeting will be published in a supplement of the Journal of Sexual Medicine.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.